From University of Nebraska Medical Center
Tech executives pulling all-nighters, athletes pushing their limits, parents juggling endless responsibilities everyones operating at full capacity
GLP-1 agonists are medicines that mimic a gut hormone that helps your body handle food more effectively
A summary of randomized controlled trials (RCTs) on these cognitive parameters is presented below
Yokota, T., Uchihara, T., Kumagai, J., Shiojiri, T., Pang, J.J., Arita, M., Arai, H., Hayashi, M., Kiyosawa, M., Okeda, R., Mizusawa, H., 2000
This three-pathway mechanism is one reason retatrutide has gained significant attention in obesity medicine and clinical research, and why many are already referring to it as the next generation of weight-loss medications. Clinical trials for retatrutide began several years ago, with Phase 2 data generating significant interest due to the amount of weight loss observed in study participants